Identification of SARS-CoV-2 3CL Protease Inhibitors by a Quantitative High-Throughput Screening

Mostrar otras versiones (1)

[Image: see text] The outbreak of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has emphasized the urgency to develop effective therapeutics. Drug repurposing screening is regarded as one of the most practical and rapid approaches for the...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Wei, Xu, Miao, Chen, Catherine Z., Guo, Hui, Shen, Min, Hu, Xin, Shinn, Paul, Klumpp-Thomas, Carleen, Michael, Samuel G., Zheng, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2020
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7507806/
https://www.ncbi.nlm.nih.gov/pubmed/33062953
http://dx.doi.org/10.1021/acsptsci.0c00108

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7507806/
https://www.ncbi.nlm.nih.gov/pubmed/33062953
http://dx.doi.org/10.1021/acsptsci.0c00108

Ejemplares similares